Quick answer
Halozyme Therapeutics, Inc. (HALO) reported diluted EPS of $1.90 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-06. Its last four 10-Q/10-K filings were on 2026-08-06, 2026-05-11, 2026-02-17, 2025-11-03.
Data as of 2026-08-06. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-06 | $1.90 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-11 | $1.22 |
| 2025-12-31 | Full year | 10-K | 2026-02-17 | $2.56 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-03 | $1.43 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-05 | $1.33 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-06 | $0.93 |
| 2024-12-31 | Full year | 10-K | 2025-02-18 | $3.43 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $1.05 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-06 | $0.72 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-07 | $0.60 |
| 2023-12-31 | Full year | 10-K | 2024-02-20 | $2.10 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-06 | $0.61 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-08 | $0.56 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-09 | $0.29 |
| 2022-12-31 | Full year | 10-K | 2023-02-21 | $1.44 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-08 | $0.44 |
Related
- GWW earnings report dates and EPS history (W.W. Grainger, Inc.)
- H earnings report dates and EPS history (Hyatt Hotels Corp)
- HAL earnings report dates and EPS history (Halliburton Company)
- HAS earnings report dates and EPS history (Hasbro, Inc.)
- HBAN earnings report dates and EPS history (Huntington Bancshares Incorporated)
- HCA earnings report dates and EPS history (HCA Healthcare, Inc.)
- HD earnings report dates and EPS history (The Home Depot, Inc.)
- HEI earnings report dates and EPS history (Heico Corporation)
Last updated Oct 16, 2026, 2:28 PM ET. Data only, not financial or tax advice.